Safety profile of triple ICS/LABA/LAMA FDC in the treatment of asthma: a meta-analysis

被引：0
|
作者：
Calzetta, L. [1 ]
Cavalli, F. [2 ]
Chetta, A. [1 ]
Cazzola, M. [2 ]
Rogliani, P. [2 ]
机构：
[1] Univ Parma, Parma, Italy
[2] Univ Roma Tor Vergata, Rome, Italy
来源：
EUROPEAN RESPIRATORY JOURNAL | 2022年 / 60卷
关键词：
Asthma; Pharmacology; Treatments;
D O I：
10.1183/13993003.congress-2022.294
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
294
引用
收藏
页数：2
相关论文
共 50 条
  • [1] TRIPLE THERAPY (ICS/LABA/LAMA) IN PATIENTS WITH UNCONTROLLED ASTHMA: A SYSTEMATIC REVIEW AND META-ANALYSIS
    Saleh, C.
    Kim, L.
    Whalen-Browne, A.
    Chu, D.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2020, 125 (05) : S37 - S38
  • [2] Triple (ICS/LABA/LAMA) vs. Dual (ICS/LABA) Therapy for Persistent, Uncontrolled Asthma: A Systematic Review and Meta-Analysis
    Kim, L.
    Saleh, C.
    Whalen-Browne, A.
    O'Byrne, P.
    Chu, D.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2021, 203 (09)
  • [3] Efficacy and safety of ICS/LABA/LAMA FDCs in COPD: a network meta-analysis
    Rogliani, P.
    Cazzola, M.
    Verri, S.
    Camardelli, F.
    Calzetta, L.
    EUROPEAN RESPIRATORY JOURNAL, 2022, 60
  • [4] Adding a LAMA to ICS/LABA Therapy A Meta-analysis of Triple Combination Therapy in COPD
    Calzetta, Luigino
    Cazzola, Mario
    Matera, Maria Gabriella
    Rogliani, Paola
    CHEST, 2019, 155 (04) : 758 - 770
  • [5] THE DOSE OF ICS IN TRIPLE ICS/LABA/LAMA FDC MODULATES INFLAMMATION IN A HUMAN EX VIVO MODEL OF SEVERE EOSINOPHILIC ASTHMA
    Rogliani, Paola
    Ora, Josuel
    Motta, Enrico
    Laitano, Rossella
    Calzetta, Luigino
    CHEST, 2023, 164 (04) : 4918A - 4918A
  • [6] Potential Drawbacks of ICS/LABA/LAMA Triple Fixed-Dose Combination Therapy in the Treatment of Asthma: A Quantitative Synthesis of Safety Profile
    Rogliani, Paola
    Cavalli, Francesco
    Chetta, Alfredo
    Cazzola, Mario
    Calzetta, Luigino
    JOURNAL OF ASTHMA AND ALLERGY, 2022, 15 : 565 - 577
  • [7] LABA/LAMA combinations versus LAMA monotherapy or LABA/ICS in COPD: a systematic review and meta-analysis
    Rodrigo, Gustavo J.
    Price, David
    Anzueto, Antonio
    Singh, Dave
    Altman, Pablo
    Bader, Giovanni
    Patalano, Francesco
    Fogel, Robert
    Kostikas, Konstantinos
    INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2017, 12 : 907 - 922
  • [8] Modulating the Level of ICS in Triple ICS/LABA/LAMA FDC: Effect Against Inflammation in a Human Ex Vivo Model of Severe Eosinophilic Asthma
    Rogliani, P.
    Ora, J.
    Motta, E.
    Melis, E.
    Facciolo, F.
    Calzetta, L.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2023, 207
  • [9] Modulating the Level of ICS in Triple ICS/LABA/LAMA FDC: Effect Against Airway Hyperresponsiveness in a Human Ex Vivo Model of Severe Eosinophilic Asthma
    Rogliani, P.
    Ora, J.
    Frugoni, C.
    Melis, E.
    Facciolo, F.
    Calzetta, L.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2023, 207
  • [10] Efficacy and Safety of High ICS Dose Fixed-Combination ICS/LABA/LAMA pMDI Compared with ICS/LABA and ICS/LABA plus LAMA in Patients with Uncontrolled Asthma: The TRIGGER Study
    Canonica, G. W.
    Virchow, J.
    Kots, M.
    Zuccaro, F.
    Carzana, E.
    Vele, A.
    Georges, G.
    Petruzzelli, S.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2019, 199
12345